Most drugs are currently developed, approved and marketed based on their effect on the majority of the population [...].

Department of Pharmacology 1st Faculty of Medicine Charles University and General University Hospital Prague 128 00 Prague Czech Republic

Zobrazit více v PubMed

Huntjens D.W., Dijkstra J.A., Verwiel L.N., Slijkhuis M., Elbers P., Welkers M.R.A., Veldkamp A.I., Kuijvenhoven M.A., de Leeuw D.C., Abdullah-Koolmees H., et al. Optimizing Antiviral Dosing for HSV and CMV Treatment in Immunocompromised Patients. Pharmaceutics. 2023;15:163. doi: 10.3390/pharmaceutics15010163. PubMed DOI PMC

Katip W., Oberdorfer P., Kasatpibal N. Effectiveness and Nephrotoxicity of Loading Dose Colistin-Meropenem versus Loading Dose Colistin-Imipenem in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Infection. Pharmaceutics. 2022;14:1266. doi: 10.3390/pharmaceutics14061266. PubMed DOI PMC

Sima M., Bobek D., Cihlarova P., Rysanek P., Rousarova J., Berousek J., Kuchar M., Vymazal T., Slanar O. Factors Affecting the Metabolic Conversion of Ciprofloxacin and Exposure to Its Main Active Metabolites in Critically Ill Patients: Population Pharmacokinetic Analysis of Desethylene Ciprofloxacin. Pharmaceutics. 2022;14:1627. doi: 10.3390/pharmaceutics14081627. PubMed DOI PMC

Zhang J., Wu M., Diao S., Zhu S., Song C., Yue J., Martins F.S., Zhu P., Lv Z., Zhu Y., et al. Pharmacokinetic/Pharmacodynamic Evaluation of Aztreonam/Amoxicillin/Clavulanate Combination against New Delhi Metallo-beta-Lactamase and Serine-beta-Lactamase Co-Producing Escherichia coli and Klebsiella pneumoniae. Pharmaceutics. 2023;15:251. doi: 10.3390/pharmaceutics15010251. PubMed DOI PMC

Hartinger J.M., Michalickova D., Dvorackova E., Hronova K., Krekels E.H.J., Szonowska B., Bednarova V., Benakova H., Kroneislova G., Zavora J., et al. Intraperitoneally Administered Vancomycin in Patients with Peritoneal Dialysis-Associated Peritonitis: Population Pharmacokinetics and Dosing Implications. Pharmaceutics. 2023;15:1394. doi: 10.3390/pharmaceutics15051394. PubMed DOI PMC

Sima M., Hartinger J., Cikankova T., Slanar O. Estimation of once-daily amikacin dose in critically ill adults. J. Chemother. 2018;30:37–43. doi: 10.1080/1120009X.2017.1376818. PubMed DOI

de Velde F., Mouton J.W., de Winter B.C.M., van Gelder T., Koch B.C.P. Clinical applications of population pharmacokinetic models of antibiotics: Challenges and perspectives. Pharmacol. Res. 2018;134:280–288. doi: 10.1016/j.phrs.2018.07.005. PubMed DOI